Histological features of medullary carcinoma and prognosis in triple-negative basal-like carcinomas of the breast

Modern Pathology

Volumn 23, Issue 10, 2010, Pages 1357-1363

  Marginean, Felicia ^a   Rakha, Emad A ^a   Ho, Bernard C ^a   Ellis, Ian O ^a   Lee, Andrew H S ^a  

^a NOTTINGHAM CITY HOSPITAL   (United Kingdom)

Author keywords

Basal; Human breast carcinoma; Inflammation; Medullary; Prognosis; Triple negative

Indexed keywords

CYTOKERATIN 14; CYTOKERATIN 17; CYTOKERATIN 5; CYTOKERATIN 6; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFLAMMATION; MAJOR CLINICAL STUDY; MEDULLARY CARCINOMA; MORPHOLOGY; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS;

AGED; BREAST NEOPLASMS; CARCINOMA, MEDULLARY; FEMALE; GENES, ERBB-2; HUMANS; IMMUNOPHENOTYPING; KAPLAN-MEIER ESTIMATE; KERATIN-14; KERATIN-17; KERATIN-5; KERATIN-6; MIDDLE AGED; PROGNOSIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; TUMOR MARKERS, BIOLOGICAL;

EID: 77957559346     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2010.123     Document Type: Article

References (29)

1. Perou CM, Sorlie T, Eisen MB, et al. Molecular portraits of human breast tumours. Nature 2000;406: 747-752.
2. Sorlie T, Tibshirani R, Parker J, et al. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci USA 2003;100:8418-8423.
3. Cheang MC, Voduc D, Bajdik C, et al. Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype. Clin Cancer Res 2008;14:1368-1376.
4. Rakha EA, Reis-Filho JS, Ellis IO. Basal-like breast cancer: a critical review. J Clin Oncol 2008;26:2568-2581.
5. Rakha EA, Elsheikh SE, Aleskandarany MA, et al. Triple-negative breast cancer: distinguishing between basal and nonbasal subtypes. Clin Cancer Res 2009;15: 2302-2310.
6. Rakha E, Ellis I, Reis-Filho J. Are triple-negative and basal-like breast cancer synonymous? Clin Cancer Res 2008;14:618; author reply 618-619.
7. Fulford LG, Easton DF, Reis-Filho JS, et al. Specific morphological features predictive for the basal phenotype in grade 3 invasive ductal carcinoma of breast. Histopathology 2006;49:22-34.
8. Rakha EA, Putti TC, Abd El-Rehim DM, et al. Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation. J Pathol 2006;208:495-506.
9. Jacquemier J, Padovani L, Rabayrol L, et al. Typical medullary breast carcinomas have a basal/myoepithelial phenotype. J Pathol 2005;207:260-268.
10. Rakha EA, Aleskandarany M, El-Sayed ME, et al. The prognostic significance of inflammation and medullary histological type in invasive carcinoma of the breast. Eur J Cancer 2009;45:1780-1787.
11. Gaffey MJ, Mills SE, Frierson HF, et al. Medullary carcinoma of the breast: interobserver variability in histopathologic diagnosis. Mod Pathol 1995;8:31-38.
12. Anderson TJ, Sufi F, Ellis IO, et al. Implications of pathologist concordance for breast cancer assessments in mammography screening from age 40 years. Hum Pathol 2002;33:365-371.
13. Pedersen L, Holck S, Schiodt T, et al. Inter- and intraobserver variability in the histopathological diagnosis of medullary carcinoma of the breast, and its prognostic implications. Breast Cancer Res Treat 1989;14:91-99.
14. Lee AHS, Gillett CE, Ryder K, et al. Different patterns of inflammation and prognosis in invasive carcinoma of the breast. Histopathology 2006;48:692-701.
15. Stoppa-Lyonnet D, Ansquer Y, Dreyfus H, et al. Familial invasive breast cancers: worse outcome related to BRCA1 mutations. J Clin Oncol 2000;18:4053-4059.
16. Abd El-Rehim DM, Ball G, Pinder SE, et al. Highthroughput protein expression analysis using tissue microarray technology of a large well-characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses. Int J Cancer 2005;116:340-350.
17. Rakha EA, El-Sayed ME, Green AR, et al. Prognostic markers in triple-negative breast cancer. Cancer 2007;109:25-32.
18. Nielsen TO, Hsu FD, Jensen K, et al. Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. Clin Cancer Res 2004;10:5367-5374.
19. Rakha EA, El-Sayed ME, Green AR, et al. Breast carcinoma with basal differentiation: a proposal for pathology definition based on basal cytokeratin expression. Histopathology 2007;50:434-438.
20. Sasa M, Bando Y, Takahashi M, et al. Screening for basal marker expression is necessary for decision of therapeutic strategy for triple-negative breast cancer. J Surg Oncol 2008;97:30-34.
21. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer I. The value of histological grade in breast cancer: experience from a large study with longterm follow-up. Histopathology 1991;19:403-410.
22. Hasebe T, Sasaki S, Imoto S, et al. Prognostic significance of fibrotic focus in invasive ductal carcinoma of the breast: a prospective observational study. Mod Pathol 2002;15:502-516.
23. Colpaert C, Vermeulen P, van Beest P, et al. Intratumoral hypoxia resulting in the presence of a fibrotic focus is an independent predictor of early distant relapse in lymph node-negative breast cancer patients. Histopathology 2001;39:416-425. (Pubitemid 32990095)
24. Kaplan EL, Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc 1958;53: 457-481.
25. Rilke F, Colnaghi MI, Cascinelli N, et al. Prognostic significance of HER-2/neu expression in breast cancer and its relationship to other prognostic factors. Int J Cancer 1991;49:44-49.
26. Kreike B, van Kouwenhove M, Horlings H, et al. Gene expression profiling and histopathological characterization of triple-negative/basal-like breast carcinomas. Breast Cancer Res 2007;9:R65.
27. Van den Eynden GG, Smid M, Van Laere SJ, et al. Gene expression profiles associated with the presence of a fibrotic focus and the growth pattern in lymph nodenegative breast cancer. Clin Cancer Res 2008;15: 2944-2952.
28. Rigaud C, Theobald S, Noel P, et al. Medullary carcinoma of the breast. A multicenter study of its diagnostic consistency. Arch Pathol Lab Med 1993; 117:1005-1008.
29. Pedersen L, Zedeler K, Holck S, et al. Medullary carcinoma of the breast, proposal for a new simplified histopathological definition. Based on prognostic observations and observations on inter- and intraobserver variability of 11 histopathological characteristics in breast carcinomas with medullary features. Br J Cancer 1991;63:591-595.